Avantor, Inc.
NYSE:AVTRMedical - Instruments & Supplies
+$0.07 today
- Market cap
- $10.41B
- Beta
- 0.96
- P/E (TTM)
- -11.7
- EPS (TTM)
- -$0.81
Volume 5.94M
Average 9.44M
AVTR Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Avantor, Inc.NYSE: AVTR
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization grows in line with its trailing trend
Q2 FY2026 depreciation & amortization of $105.6M rose 2.8% year over year, in line with the +3.1% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 0.6% from the prior quarter. Over 3 fiscal years it compounded at +0.4% a year.
Context
- Depreciation & amortization amounted to 6.3% of revenue in FY2025, up 0.3 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +2.8% toward the trailing-twelve-month pace of +3.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 410.2M USD
- Year-over-year change
- +1.2%
- 4-year CAGR
- +2.0%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 410.2M | +1.2% |
| FY2024 | 2024-12-31 | 405.5M | +0.8% |
| FY2023 | 2023-12-31 | 402.3M | -0.8% |
| FY2022 | 2022-12-31 | 405.5M | +6.9% |
| FY2021 | 2021-12-31 | 379.2M | — |
Depreciation & Amortization vs competitors
How AVTR compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +3.1% is the 2nd highest of 9, against a peer median of -21.8%.
- Depreciation & amortization amounts to 6.4% of revenue for AVTR, versus a peer median of 7.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $1.91B USD | -21.1% | +4.7% | 7.5% | |
| LTM Jun 2026 | $418.4M USD | +3.1% | +0.4% | 6.4% | |
| LTM Jun 2026 | $297.88M USD | -30.8% | +9.9% | 7.4% | |
| LTM Jun 2026 | $180.8M USD | +11.4% | +12.4% | 5.4% | |
| LTM Jun 2026 | $127.6M USD | -23.5% | +6.4% | 4.9% | |
| LTM Jun 2026 | $97.31M USD | -7.0% | +19.4% | 12.4% | |
| LTM Jun 2026 | €95.21M EUR | -22.5% | +11.0% | 7.8% | |
| LTM Sep 2026 | $56.52M USD | -7.7% | -12.9% | 9.1% | |
| LTM Mar 2026 | $4M USD | -48.5% | -34.2% | 4.0% | |
| Peer median (excluding AVTR) | — | -21.8% | +8.1% | 7.5% | |
Competitors are the stored peer set for AVTR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 572.6M | 686.5M | 321.1M | 711.5M | (530.2M) |
| Depreciation & Amortization | 379.2M | 405.5M | 402.3M | 405.5M | 410.2M |
| Deferred Income Tax | (17.7M) | (69.1M) | (172.4M) | (46.9M) | 7.7M |
| Stock-Based Compensation | 50.7M | 45.8M | 40.5M | 46.8M | 46.4M |
| Change in Working Capital | (114.5M) | (321.3M) | 16.6M | 47.7M | (198.9M) |
| Accounts Receivables | (111.8M) | (45.2M) | 77M | 45.9M | 13.6M |
| Inventory | (129.8M) | (112.5M) | 30.3M | (18.5M) | (109.4M) |
| Accounts Payables | 64.9M | 15.6M | (139.6M) | 59.6M | 42.4M |
| Other Working Capital | 62.2M | (179.2M) | 48.9M | (39.3M) | (145.5M) |
| Other Non-Cash Items | 83.3M | 96.2M | 261.9M | (323.8M) | 888.6M |
| Operating Cash Flow | 953.6M | 843.6M | 870M | 840.8M | 623.8M |
| Capital Expenditures | (111.1M) | (133.4M) | (146.4M) | (148.8M) | (128.8M) |
| Acquisitions (Net) | (4.01B) | (20.2M) | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 42.5M | 0 | 0 | 0 |
| Other Investing Activities | 3.5M | 1.5M | 2.7M | 587.7M | (1.7M) |
| Investing Cash Flow | (4.12B) | (109.6M) | (143.7M) | 438.9M | (130.5M) |
| Debt Repayment | 2.3B | (620.4M) | (846M) | (1.34B) | (318.7M) |
| Common Stock Issued | 967M | 0 | 0 | 0 | 5.1M |
| Common Stock Repurchased | (25.8M) | (13.2M) | (13.7M) | (8.6M) | (80.7M) |
| Dividends Paid | (64.6M) | (32.4M) | 0 | 0 | 0 |
| Other Financing Activities | 41.9M | 17.3M | 16M | 69.2M | (15.1M) |
| Financing Cash Flow | 3.22B | (648.7M) | (843.7M) | (1.28B) | (409.4M) |
| Effect of Forex Changes | (13.2M) | (15.5M) | 8.2M | (21.5M) | 19.7M |
| Net Change in Cash | 37.9M | 69.8M | (109.2M) | (23M) | 103.6M |
| Free Cash Flow | 842.5M | 710.2M | 723.6M | 692M | 495M |
Avantor, Inc.
NYSE:AVTR
Intrinsic Alpha fair value
Locked
Current Price
$15.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.